William Haskins, based in South San Francisco, CA, US, is currently a CEO and Co-Founder at Gryphon Bio, Inc., bringing experience from previous roles at Owl Therapeutics, 2stringz, LLC, 4D Molecular Therapeutics and Catalent Pharma Solutions. William Haskins holds a 1998 - 2003 PhD in Bioanalytical Chemistry of the Brain @ University of Florida. With a robust skill set that includes Biochemistry, Protein Chemistry, Proteomics, Science, Cancer and more, William Haskins contributes valuable insights to the industry. William Haskins has 2 emails and 1 mobile phone number on RocketReach.